Reduction of infarct size by the NO donors sodium nitroprusside and spermine/NO after transient focal cerebral ischemia in rats

Brain Research

Volumn 865, Issue 2, 2000, Pages 149-156

  Salom, Juan B ^a,b   Ortí, Marta ^a,b   Centeno, José M ^a,b   Torregrosa, Germán ^a,b   Alborch, Enrique ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cerebral infarct; Disorders of the nervous system; Focal ischemia; Ischemia; NO donor; Rat

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM; SPERMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPOTENSION; LASER DOPPLER FLOWMETRY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; BRAIN; CEREBRAL INFARCTION; ISCHEMIC ATTACK, TRANSIENT; MALE; NITRIC OXIDE DONORS; NITROPRUSSIDE; RATS; RATS, WISTAR; SPERMINE; VASODILATOR AGENTS;

EID: 0034717216     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02095-3     Document Type: Article

References (50)

1. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
2. Butterworth R.J., Cluckie A., Jackson S.H.D., Buxton-Thomas M., Bath P.M.W. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc. Dis. 8:1998;158-165.
3. Chi O.Z., Wei H.M., Weiss H.R. Effects of CAS 754, a new nitric oxide donor, on regional cerebral blood flow in focal cerebral ischemia. Anesth. Analg. 80:1995;703-708.
4. Coert B.A., Anderson R.E., Meyer F.B. A comparative study of the effects of two nitric oxide synthase inhibitors and two nitric oxide donors on temporary focal cerebral ischemia in the Wistar rat. J. Neurosurg. 90:1999;332-338.
5. Coert B.A., Anderson R.E., Meyer F.B. Cerebroprotection in focal cerebral ischemia by an exogenous polyamine: spermine. J. Cereb. Blood Flow Metab. 19:(Suppl. 1):1999;S185.
6. Corbett D., Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog. Neurobiol. 54:1998;531-548.
7. Curry S.C., Arnold-Capell P. Toxic effects of drugs used in the ICU. Nitroprusside, nitroglycerin, and angiotensin-converting enzyme inhibitors. Crit. Care Clin. 7:1991;555-581.
8. Dogan A., Muralikrishna Rao A., Hatcher J., Raghavendra Rao V.L., Baskaya M.K., Dempsey R.J. Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. J. Neurochem. 72:1999;765-770.
9. Escott K.J., Beech J.S., Haga K.K., Williams S.C.R., Meldrum B.S., Bath P.M.W. Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:1998;281-287.
10. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17:(Suppl.3):1991;S25-S33.
11. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;113-122.
12. Friederich J.A., Butterworth J.F. Sodium nitroprusside: twenty years and counting. Anesth. Analg. 81:1995;152-162.
13. García J.H., Yoshida Y., Chen H., Li Y., Zhang Z.G., Lian J., Chen S., Chopp M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am. J. Pathol. 142:1993;623-635.
14. Gelb A.W., Boisvert D.P., Tang C., Lam A.M., Marchak B.E., Dowman R., Mielke B.W. Primate brain tolerance to temporary focal cerebral ischemia during isoflurane- or sodium nitroprusside-induced hypotension. Anesthesiology. 70:1989;678-683.
15. Gunasekar P.G., Sun P.W., Kanthasamy A.G., Borowitz J.L., Isom G.E. Cyanide-induced neurotoxicity involves nitric oxide and reactive oxygen species generation after N-methyl-D-aspartate receptor activation. J. Pharmacol. Exp. Ther. 277:1996;150-155.
16. Hara H., Huang P.L., Panahian N., Fishman M.C., Moskowitz M.A. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16:1996;605-611.
17. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16:1996;981-987.
18. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
19. Iadecola C., Zhang F., Casey R., Clark H.B., Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 27:1996;1373-1380.
20. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17:1997;9157-9164.
21. Iadecola C., Zhang F., Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268:1995;R286-R292.
22. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
23. Ivankovich A.D., Braverman B., Stephens T.S., Shulman M., Heyman H.J. Sodium thiosulfate disposition in humans: relation to sodium nitroprusside toxicity. Anesthesiology. 58:1983;11-17.
24. Johnson T.D. Polyamines and cerebral ischemia. Prog. Drug Res. 50:1998;193-258.
25. Kiedrowski L., Manev H., Costa E., Wroblewski J.T. Inhibition of glutamate-induced cell death by sodium nitroprusside is not mediated by nitric oxide. Neuropharmacology. 30:1991;1241-1243.
26. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
27. Maduh E.U., Turek J.J., Borowitz J.L., Rebar A., Isom G.E. Cyanide-induced neurotoxicity: calcium mediation of morphological changes in neuronal cells. Toxicol. Appl. Pharmacol. 103:1990;214-221.
28. Maragos C.M., Morley D., Wink D.A., Dunams T.M., Saavedra J.E., Hoffman A., Bove A.A., Isaac L., Hrabie J.A., Keefer L.K. Complexes of NO with nucleotides as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 34:1991;3242-3247.
29. Morikawa E., Huang Z., Moskowitz M.A. L-arginine decreases infarct size caused by middle cerebral artery occlusion in SRH. Am. J. Physiol. 263:1992;H1632-H1635.
30. Morikawa E., Moskowitz M.A., Huang Z., Yoshida T., Irikura K., Dalkara T. L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke. 25:1994;429-435.
31. Morikawa E., Rosenblatt S., Moskowitz M.A. L-arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischemia. Br. J. Pharmacol. 107:1992;905-907.
32. Morley D., Keefer L.K. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J. Cardiovasc. Pharmacol. 22:(Suppl.7):1993;S3-S9.
33. Nagafuji T., Sugiyama M., Muto A., Makino T., Miyauchi T., Nabata H. The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. Neuroreport. 6:1995;1541-1545.
34. Nagayama M., Zhang F., Iadecola C. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J. Cereb. Blood Flow Metab. 18:1998;1107-1113.
35. Nicchitta C., Williamson J.R. Spermine: a regulator of mitochondrial calcium cycling. J. Biol. Chem. 259:1984;12978-12983.
36. Paschen W. Polyamine metabolism in reversible cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 4:1992;59-88.
37. Paschen W., Csiba L., Röhn G., Bereczki D. Polyamine metabolism in transient focal ischemia of rat brain. Brain Res. 566:1991;354-357.
38. Ramos-Zúñiga R., Velázquez-Santana H., Mercado-Pimentel R., Cerda-Camacho F. Neuroprotection in selective focal ischemia in rats by nitrates, an alternative redox manipulation of nitric oxide: experimental model. Minimally Invasive Neurosurg. 41:1998;152-160.
39. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., Reulen H.-J. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia. Evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke. 29:1998;2162-2170.
40. Seiler N. Polyamine oxidase, properties and functions. Prog. Brain Res. 106:1995;333-344.
41. Verrecchia C., Boulu R.G., Plotkine M. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neurone death. Adv. Neuroimmunol. 5:1995;359-378.
42. Winquist R.J., Kerr S. Cerebral ischemia-reperfusion injury and adhesion. Neurology. 49:(Suppl. 4):1997;S23-S26.
43. Yang C.W., Borowitz J.L., Gunasekar P.G., Isom G.E. Cyanide-stimulated inositol 1,4,5-triphosphate formation: an intracellular neurotoxic signalling cascade. J. Biochem. Toxicol. 11:1996;251-256.
44. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
45. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.
46. Zhang F., Iadecola C. Fastigial stimulation increases ischemic blood flow and reduces brain damage after focal ischemia. J. Cereb. Blood Flow Metab. 13:1993;1013-1019.
47. Zhang F., Iadecola C. Nitroprusside improves blood flow and reduces brain damage after focal ischemia. Neuroreport. 5:1993;559-562.
48. Zhang F., Iadecola C. Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J. Cereb. Blood Flow Metab. 14:1994;574-580.
49. Zhang F., White J.G., Iadecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J. Cereb. Blood Flow Metab. 14:1994;217-226.
50. Zhang Z.G., Reif D., Macdonald J., Tang W.X., Kamp D.K., Gentile R.J., Shakespeare W.C., Murray R.J., Chopp M. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:1996;599-604.